California’s Newsom Slams Congress for ‘Dumb’ Immigration Policy
(Bloomberg) -- California Governor Gavin Newsom slammed US House Speaker Kevin McCarthy for the country’s broken immigration system as tens of thousands of migrants gather at the Mexico border and cities from New York to San Diego prepare for the arrival of thousands more.
Most Read from Bloomberg
Turkey Latest: Erdogan Vote Below 50% Needed to Win Election
Early Vote Count Shows Erdogan Below 50% in Turkish Election
Trump Changed GOP Rules to Make Winning the Nomination Even Easier — for Trump
“He’s done nothing fundamentally to address this issue since he’s been speaker, and frankly, since he’s been in Congress,” the Democratic governor said Friday of McCarthy, a Republican who represents a district in California’s Central Valley.
“So forgive me for being so damn pointed, but we’re as dumb as we want to be as a nation on this,” Newsom said.
He made the comments while unveiling California’s revised budget proposal, forecasting a $32 billion deficit partly due to weaker tax revenue from its wealthiest residents. The expected shortfall has grown by $9.3 billion since Newsom’s initial estimate in January, marking a sharp turnaround after years of surpluses.
Worsening economic conditions, violence and political upheaval in Latin America have led to a rapid influx of migrants at the US border hoping to claim asylum, creating a humanitarian crisis and straining the immigration system.
Read more: NYC, Chicago Clash With Biden as Migrant Surge Crushes Funds
The situation is expected to worsen following the expiration late Thursday of a pandemic-era measure known as Title 42 that allowed authorities to quickly expel migrants.
“What’s happening at the border is a manifestation of our failure to fundamentally address the need for comprehensive reform,” Newsom said.
Most Read from Bloomberg Businessweek
The Plot to Steal the Other Secret Inside a Can of Coca-Cola
How Normalizing Menopause Can Help Employers Retain Senior Women
AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma
©2023 Bloomberg L.P.
